Hdl348
发表于 2025-3-25 07:00:17
http://reply.papertrans.cn/63/6220/621987/621987_21.png
cliche
发表于 2025-3-25 09:38:49
http://reply.papertrans.cn/63/6220/621987/621987_22.png
CHOKE
发表于 2025-3-25 13:24:11
http://reply.papertrans.cn/63/6220/621987/621987_23.png
宽敞
发表于 2025-3-25 17:49:09
http://reply.papertrans.cn/63/6220/621987/621987_24.png
canonical
发表于 2025-3-25 20:50:29
http://reply.papertrans.cn/63/6220/621987/621987_25.png
威胁你
发表于 2025-3-26 00:52:11
Prognostic factors in intermediate high grade lymphoma,ually by survival. This information would lead to a more rational approach to an individual case where treatment to be offered to patients with a worse than average prognosis could be intensified or dramatically changed, while the better prognostic subgroup of patients could benefit from conventiona
crockery
发表于 2025-3-26 06:39:19
Treatment of diffuse large-cell lymphoma: A summary of outcome for patients treated by the Southwesd with a potential for cure following initial treatment with doxorubicin-containing chemotherapy. Consequently, DLCL has become a chosen target of investigators testing new therapies designed for cure. By choosing to study a single morphologic disease, and by standardizing procedures used to determi
形状
发表于 2025-3-26 08:59:35
http://reply.papertrans.cn/63/6220/621987/621987_28.png
易发怒
发表于 2025-3-26 13:59:34
Lymphoblastic lymphoma, a disease having discreet pathologic and clinical features from diffuse, small cleaved cell lymphoma. In 1982, the National Cancer Institute sponsored study of 1175 adult patients [.] gave rise to the international Working Formulation of non-Hodgkin’s lymphomas, which recognized LBL as one of its 1
EVADE
发表于 2025-3-26 18:42:25
http://reply.papertrans.cn/63/6220/621987/621987_30.png